These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24913241)

  • 21. Cost-utility analysis of bariatric surgery.
    Borisenko O; Lukyanov V; Ahmed AR
    Br J Surg; 2018 Sep; 105(10):1328-1337. PubMed ID: 29667178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are we operating too late? Mortality Analysis and Stochastic Simulation of Costs Associated with Bariatric Surgery: Reconsidering the BMI Threshold.
    Sinha AC; Singh PM; Bhat S
    Obes Surg; 2016 Jan; 26(1):219-28. PubMed ID: 26487650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term medication cost savings for treating hypertension and diabetes after gastric bypass.
    Ghiassi S; Morton J; Bellatorre N; Eisenberg D
    Surg Obes Relat Dis; 2012; 8(3):269-74. PubMed ID: 21723203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing cost of surgery by avoiding complications: the model of robotic Roux-en-Y gastric bypass.
    Hagen ME; Pugin F; Chassot G; Huber O; Buchs N; Iranmanesh P; Morel P
    Obes Surg; 2012 Jan; 22(1):52-61. PubMed ID: 21538177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-utility analysis of bariatric surgery compared with conventional medical management in Germany: a decision analytic modeling.
    Borisenko O; Mann O; Duprée A
    BMC Surg; 2017 Aug; 17(1):87. PubMed ID: 28774333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in Health-Related Quality of Life After Gastric Bypass in Patients With and Without Obesity-Related Disease.
    Risstad H; Søvik TT; Hewitt S; Kristinsson JA; Fagerland MW; Bernklev T; Mala T
    Obes Surg; 2015 Dec; 25(12):2408-16. PubMed ID: 26003550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost analysis of bariatric surgery in Denmark made with a decision-analytic model.
    Borisenko O; Lukyanov V; Johnsen SP; Funch-Jensen P
    Dan Med J; 2017 Aug; 64(8):. PubMed ID: 28869031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Timing of bariatric surgery for severely obese adolescents: a Markov decision-analysis.
    Stroud AM; Parker D; Croitoru DP
    J Pediatr Surg; 2016 May; 51(5):853-8. PubMed ID: 27261561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopic gastric bypass: risks vs. benefits up to two years following surgery in super-super obese patients.
    Gould JC; Garren MJ; Boll V; Starling JR
    Surgery; 2006 Oct; 140(4):524-9; discussion 529-31. PubMed ID: 17011899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of insulin aspart versus human soluble insulin in type 2 diabetes in four European countries: subgroup analyses from the PREDICTIVE study.
    Palmer JL; Goodall G; Nielsen S; Kotchie RW; Valentine WJ; Palmer AJ; Roze S
    Curr Med Res Opin; 2008 May; 24(5):1417-28. PubMed ID: 18400145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing cost-effectiveness in obesity: laparoscopic adjustable gastric banding for severely obese adolescents.
    Ananthapavan J; Moodie M; Haby M; Carter R
    Surg Obes Relat Dis; 2010; 6(4):377-85. PubMed ID: 20655020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bariatric surgery for the treatment of severely obese patients in South Korea--is it cost effective?
    Song HJ; Kwon JW; Kim YJ; Oh SH; Heo Y; Han SM
    Obes Surg; 2013 Dec; 23(12):2058-67. PubMed ID: 23636995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of Bariatric Surgery in Adolescents With Obesity.
    Klebanoff MJ; Chhatwal J; Nudel JD; Corey KE; Kaplan LM; Hur C
    JAMA Surg; 2017 Feb; 152(2):136-141. PubMed ID: 27784062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of intraoperative conversion from off-pump to on-pump coronary artery bypass grafting on costs and quality of life: a cost-effectiveness analysis.
    Shiga T; Apfel CC; Wajima Z; Ohe Y
    J Cardiothorac Vasc Anesth; 2007 Dec; 21(6):793-9. PubMed ID: 18068054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness analysis of cholecystectomy during Roux-en-Y gastric bypass for morbid obesity.
    Benarroch-Gampel J; Lairson DR; Boyd CA; Sheffield KM; Ho V; Riall TS
    Surgery; 2012 Sep; 152(3):363-75. PubMed ID: 22938897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-Utility Analysis of Bariatric Surgery in Italy: Results of Decision-Analytic Modelling.
    Lucchese M; Borisenko O; Mantovani LG; Cortesi PA; Cesana G; Adam D; Burdukova E; Lukyanov V; Di Lorenzo N
    Obes Facts; 2017; 10(3):261-272. PubMed ID: 28601866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of Roux-en-Y gastric bypass on prescription drug costs.
    Snow LL; Weinstein LS; Hannon JK; Lane DR; Ringold FG; Hansen PA; Pointer MD
    Obes Surg; 2004 Sep; 14(8):1031-5. PubMed ID: 15479590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medication cost is significantly reduced after Roux-en-Y gastric bypass in obese patients.
    Gesquiere I; Aron-Wisnewsky J; Foulon V; Haggege S; Van der Schueren B; Augustijns P; Bouillot JL; Clement K; Basdevant A; Oppert JM; Buyse M
    Obes Surg; 2014 Nov; 24(11):1896-903. PubMed ID: 24947346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain.
    Shearer AT; Bagust A; Ampudia-Blasco FJ; Martínez-Lage Alvarez B; Pérez Escolano I; París G
    Pharmacoeconomics; 2006; 24 Suppl 1():49-59. PubMed ID: 16800162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bariatric surgery: a systematic review of the clinical and economic evidence.
    Padwal R; Klarenbach S; Wiebe N; Hazel M; Birch D; Karmali S; Sharma AM; Manns B; Tonelli M
    J Gen Intern Med; 2011 Oct; 26(10):1183-94. PubMed ID: 21538168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.